美国实体器官移植受者皮肤癌发病率及危险因素
移植后皮肤癌总发病率为1437/10万人年,鳞状细胞癌、黑色素瘤和默克尔细胞癌分别为812、75和2/10万人年。移植前皮肤癌史、男性、白人种族、移植年龄≥50岁及2008年移植与风险升高相关。
要点
- 移植后皮肤癌常见,总发病率1437/10万人年。
- 鳞状细胞癌发病率最高(812/10万人年)。
- 移植前皮肤癌史、白人、男性、年龄≥50岁及2008年移植为危险因素。
核心结论
- 移植后皮肤癌常见,风险受年龄、白人种族、男性及胸部器官移植影响,并存在时间队列效应。
主要发现
- 移植后皮肤癌总发病率为1437/10万人年。
- 鳞状细胞癌发病率为812/10万人年,黑色素瘤为75/10万人年,默克尔细胞癌为2/10万人年。
- 移植前皮肤癌史HR为4.69(95%CI 3.26-6.73)。
- 男性HR为1.56(95%CI 1.34-1.81),白人种族HR为9.04(95%CI 6.20-13.18)。
- 移植年龄≥50岁HR为2.77(95%CI 2.20-3.48),2008年 vs 2003年移植HR为1.53(95%CI 1.22-1.94)。
临床怎么用
- 应针对高危移植受者(如移植前皮肤癌史、白人、男性、年龄≥50岁)进行针对性筛查和预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Skin cancer is the most common malignancy occurring after organ transplantation. Although previous research has reported an increased risk of skin cancer in solid organ transplant recipients (OTRs), no study has estimated the posttransplant population-based incidence in the United States. OBJECTIVE: To determine the incidence and evaluate the risk factors for posttransplant skin cancer, including squamous cell carcinoma (SCC), melanoma (MM), and Merkel cell carcinoma (MCC) in a cohort of US OTRs receiving a primary organ transplant in 2003 or 2008. DESIGN, SETTING, AND PARTICIPANTS: This multicenter retrospective cohort study examined 10 649 adult recipients of a primary transplant performed at 26 centers across the United States in the Transplant Skin Cancer Network during 1 of 2 calendar years (either 2003 or 2008) identified through the Organ Procurement and Transplantation Network (OPTN) database. Recipients of all organs except intestine were included, and the follow-up periods were 5 and 10 years. MAIN OUTCOMES AND MEASURES: Incident skin cancer was determined through detailed medical record review. Data on predictors were obtained from the OPTN database. The incidence rates for posttransplant skin cancer overall and for SCC, MM, and MCC were calculated per 100 000 person-years. Potential risk factors for posttransplant skin cancer were tested using multivariate Cox regression analysis to yield adjusted hazard ratios (HR). RESULTS: Overall, 10 649 organ transplant recipients (mean [SD] age, 51 [12] years; 3873 women [36%] and 6776 men [64%]) contributed 59 923 years of follow-up. The incidence rates for posttransplant skin cancer was 1437 per 100 000 person-years. Specific subtype rates for SCC, MM, and MCC were 812, 75, and 2 per 100 000 person-years, respectively. Statistically significant risk factors for posttransplant skin cancer included pretransplant skin cancer (HR, 4.69; 95% CI, 3.26-6.73), male sex (HR, 1.56; 95% CI, 1.34-1.81), white race (HR, 9.04; 95% CI, 6.20-13.18), age at transplant 50 years or older (HR, 2.77; 95% CI, 2.20-3.48), and being transplanted in 2008 vs 2003 (HR, 1.53; 95% CI, 1.22-1.94). CONCLUSIONS AND RELEVANCE: Posttransplant skin cancer is common, with elevated risk imparted by increased age, white race, male sex, and thoracic organ transplantation. A temporal cohort effect was present. Understanding the risk factors and trends in posttransplant skin cancer is fundamental to targeted screening and prevention in this population.
引用
- Garrett GL, Blanc PD, Boscardin J, et al. Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States. JAMA Dermatol. 2017. PMID: 28097368. doi:10.1001/jamadermatol.2016.4920
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。